Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04421690
Other study ID # 2021943
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date June 8, 2020
Est. completion date June 30, 2022

Study information

Verified date March 2023
Source University of Missouri-Columbia
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this research is to look at the effects of computerized cognitive training on anxiety, sleep, mental abilities (cognition), and other aspects of daytime functioning, such as arousal.


Recruitment information / eligibility

Status Completed
Enrollment 30
Est. completion date June 30, 2022
Est. primary completion date June 30, 2022
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 45 Years to 59 Years
Eligibility Inclusion Criteria: - 45-59 yrs of age - no neurological or psychiatric illness, dementia, or loss of consciousness > 5 mins - nongamers (i.e., report <1 hour of video/cognitive training games/week over last 2 yrs) - proficient in English (reading and writing) - computer meets technology requirements (i.e. Windows: Windows 7 or above using Internet Explorer 11 or Edge, Mozilla Firefox 41 and above, Google Chrome 48 and above; Mac OS: Mac OS X v10.8 and above using Safari 10 and above, Mozilla Firefox 42 and above, Google Chrome 48 and above; Android App: Android 6 or higher version; iOS App: iOS 10 or higher version - meet clinical dx criteria for Generalized Anxiety Disorder. Exclusion Criteria: - unable to provide informed consent - unable to undergo randomization - Telephone Interview for Cognitive Status-modified (TICS) score <33, 2) - other sleep disorder (i.e., sleep apnea, Periodic Limb Movement Disorder-PLMD, narcolepsy, REM Sleep Behavior Disorder) - severe untreated psychiatric comorbidity that renders randomization unethical - psychotropic, anxiolytic medications or other medications(e.g., beta-blockers) that alter mood or sleep - uncorrected visual/auditory impairments - participation in nonpharmacological treatment for sleep/fatigue/mood outside the current study.

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Cognitive Training
Participants (n=15) will complete computerized cognitive training games and activities online 3 times/week for 8 weeks.
Trivia Training
Participants (n=15) will receive computerized trivia questions to answer and submit 3 times/week for 8 weeks.

Locations

Country Name City State
United States University of Missouri Columbia Missouri

Sponsors (1)

Lead Sponsor Collaborator
University of Missouri-Columbia

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Objective Cognition - Computerized Cognitive Tasks Complete computerized tasks. These tasks will measure cognitive functions (e.g., processing speed). Up to 10 weeks
Primary Objective Cognition - Computerized Cognitive Tasks Complete computerized tasks. These tasks will measure cognitive functions (e.g., attention). Up to 10 weeks
Primary Objective Cognition - Computerized Cognitive Tasks Complete computerized tasks. These tasks will measure cognitive functions (e.g., executive function). Up to 10 weeks
Primary Subjective Cognitive Self-Efficacy. -Cognitive Failures Questionnaire A 25-item questionnaire. Participants rate from 0 (never) to 4 (very often) frequency of cognitive errors. Higher scores indicate lower cognitive self-efficacy. Up to 10 weeks
Primary Coronavirus Anxiety Scale 5- item questionnaire that assess anxiety related to the Coronavirus. Up to 10 weeks
Primary Anxiety - State-Trait Anxiety Inventory Inventory that asks respondents to rate how true 20 self-descriptive statements (e.g., I feel calm) are on a 4-point scale (1 = not at all, 4 = very much so). Typically, respondents are asked to rate statements according to how they generally feel (trait-anxiety scale) and how they feel in the current moment (state-anxiety scale). Total scores range from 20 to 80, with higher scores indicating greater maladjustment. Up to 10 weeks
Secondary Game-related experience- Sessions and duration played During the intervention phase the cognitive training group will play games and will need to log the days and duration played. Up to 10 weeks
Secondary Circadian Rhythm- Morningness-Eveningness Questionnaire 19-item questionnaire that assesses preference for morning, afternoon, and evening activities. Total score reflects degree of "morningness" or "eveningness" type. Up to 10 weeks
Secondary Subjective Arousal- Global Cognitive Arousal-Perceived Stress Scale Perceived Stress Scale is a self-report measure of how life situations are perceived as stressful. The scale consists of 15 items corresponding to everyday situation and participants are asked to rate on a likert scale from 0 (never) to 4 (very often) how often they felt or thought a specific way. Higher scores correspond to higher perceived stress. Up to 10 weeks
Secondary Subjective Arousal- Pre-sleep Arousal Scale Pre-sleep Arousal Scale is a 16-item self-report questionnaire comprising both cognitive and somatic manifestations of arousal. Up to 10 weeks
Secondary Subjective Arousal- Arousal Predisposition Scale Subjective Arousal- Arousal Predisposition Scale Subjective Arousal- Arousal Predisposition Scale Arousal Predisposition Scale is a 12-item inventory that has been designed to measure the degree to which an individual experiences arousal. Higher scores indicate greater predisposition to arousal. Up to 10 weeks
Secondary Game Engagement Questionnaire Questionnaire assessing the experience of the game. Up to 10 weeks
Secondary Mood-Depression-Beck Depression Inventory-II 21-item inventory that asks respondents to rate on a scale of 0 (no depressive feelings) to 3 (most depressive feelings) their feelings towards various aspects of daily living/situations. Higher total scores indicate worse depressive symptoms. Up to 10 weeks
Secondary Alcohol Use - Alcohol Use Disorder Test 10-item questionnaire that assess the frequency of alcohol use and problems associated with alcohol use over the past year. Baseline
Secondary Physical Activity - International Physical Activity Questionnaire 7- item questionnaire assessing the different kinds of physical activities that the participant does as pat of their everyday life. Up to 10 weeks
Secondary Personality - Big Five Inventory 10 question assessment measuring personality. Baseline
Secondary COVID-19 related media exposure and risk questions 20- item questionnaire assessing the effects of news and social media on perception of COVID-19. Up to 10 weeks
Secondary Subjective Intervention Efficacy- Internet Intervention Utility Questionnaire 16- item questionnaire about the use of the intervention. Up to 10 weeks
Secondary Computer Proficiency- Computer Proficiency Questionnaire This questionnaire asks about participants' ability to perform a number of tasks with a computer. Will be examined as a covariate. Baseline
Secondary Subjective Behavioral Sleep- Insomnia Severity Index Brief self-report measure of current perception of insomnia symptom severity, distress and daytime impairment. Commonly used in insomnia treatment outcome research. Up to 10 weeks
Secondary Beck Depression Inventory-2nd Edition 21-item inventory that asks respondents to rate on a scale of 0 (no depressive feelings) to 3 (most depressive feelings) their feelings towards various aspects of daily living/situations. Higher total scores indicate worse depressive symptoms. Up to 10 weeks
Secondary Subjective Behavioral Sleep - Electronic Daily Sleep Diaries Online diaries completed each morning (~5 mins); diaries measure sleep onset latency, wake time after sleep onset, total sleep time, and sleep quality. Up to 10 weeks
Secondary Subjective Behavioral Sleep - Electronic Daily Sleep Diaries Online diaries completed each morning (~5 mins); diaries measure sleep onset latency Up to 10 weeks
Secondary Subjective Behavioral Sleep - Electronic Daily Sleep Diaries Online diaries completed each morning (~5 mins); diaries measure wake time after sleep onset Up to 10 weeks
Secondary Subjective Behavioral Sleep - Electronic Daily Sleep Diaries Online diaries completed each morning (~5 mins); diaries measure total sleep time Up to 10 weeks
Secondary Subjective Behavioral Sleep - Electronic Daily Sleep Diaries Online diaries completed each morning (~5 mins); diaries measure sleep quality Up to 10 weeks
See also
  Status Clinical Trial Phase
Terminated NCT03420456 - Transcranial Pulse Near-Infrared Light in Generalized Anxiety Disorder: a Placebo-Controlled Study N/A
Active, not recruiting NCT05530642 - An Augmented Training Program for Preventing Post-Traumatic Stress Injuries Among Diverse Public Safety Personnel N/A
Withdrawn NCT02382224 - Worry Exposure for Generalized Anxiety Disorder N/A
Completed NCT02306356 - Internet-delivered Treatment for Children With Anxiety Disorders in a Rural Area; an Open Trial in a Clinical Setting N/A
Completed NCT02256566 - Cognitive Training for Mood and Anxiety Disorders N/A
Completed NCT01958788 - Testing Beliefs About Uncertainty in the Treatment of Generalized Anxiety Disorder N/A
Completed NCT01681329 - Cognitive-Behavioral Treatment and Interpretation Modification Training for Adults With Generalized Anxiety Disorder N/A
Completed NCT01201967 - A Collaborative Care Program to Improve Treatment of Depression and Anxiety Disorders in Cardiac Patients Phase 4
Completed NCT01342120 - PHARMO Institute Seroquel Safety Study N/A
Completed NCT01337713 - Efficacy of Massage Therapy in the Treatment of Generalized Anxiety Disorder (GAD) N/A
Completed NCT01203293 - Cognitive Behavioral Therapy (CBT) for Latinos With Generalized Anxiety Disorder in the General Medical Sector Phase 1
Completed NCT01971203 - Efficacy of Extended-release Quetiapine (Seroquel XR) as Adjunctive Therapy to Cognitive Behavioral Therapy in the Treat N/A
Completed NCT00961298 - An Open Label Trial of Duloxetine in the Treatment of Irritable Bowel Syndrome and Comorbid Generalized Anxiety Disorder Phase 4
Completed NCT00711737 - Study of the Changes in Metabolic Parameters in Patients Treated With Escitalopram for Six Months N/A
Completed NCT00744627 - Efficacy and Safety of Vortioxetine (Lu AA21004) for Treatment of Generalized Anxiety Disorder in Adults. Phase 3
Terminated NCT01244711 - Open-Label Pilot Study to Examine the Value of Substituting Quetiapine for Benzodiazepines Phase 4
Completed NCT00537615 - An Open-label Study to Investigate the Absorption, Metabolism and Excretion of Radiolabeled PD 0332334 in Six Healthy Male Volunteers Phase 1
Completed NCT00525226 - Evaluating the Effects of Stress in Pregnancy N/A
Completed NCT00515242 - Therapeutic Massage for Generalized Anxiety Disorder Phase 1/Phase 2
Completed NCT00368745 - Efficacy and Safety of Pregabalin vs Placebo for Generalized Anxiety Disorder (GAD) Symptoms in Subjects Discontinuing Benzodiazepine Treatment and Remaining 6 Weeks on Study Medication, Free From Benzodiazepine Use. Phase 3